Cover Image
市場調查報告書

歐洲的女性用·子宮頸避孕設備市場分析

European Market Report for Transcervical Female Sterilization

出版商 iData Research Inc. 商品編碼 371088
出版日期 內容資訊 英文 62 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
歐洲的女性用·子宮頸避孕設備市場分析 European Market Report for Transcervical Female Sterilization
出版日期: 2016年09月01日 內容資訊: 英文 62 Pages
簡介

本報告提供歐洲各國女性用·子宮頸避孕用設備的市場相關分析,提供您技術·產品概要,及整體市場規模的實際成果值·預測值,各產品詳細趨勢,主要的推動及阻礙市場要素,主要企業的市場佔有率,各國市場的市場結構等調查評估。

摘要整理

歐洲的婦產科用醫療設備的市場:概要

競爭分析

市場趨勢

市場發展

治療數量

分析對象市場

主要報告的更新情形

過去的版本

調查手法

  • 調查範圍
  • IDATA的9等級分析方法

各國市場簡介

  • 簡介
    • 人口
    • 平均年齡
    • 每人GDP
    • 價格指數
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 荷比盧三國
  • 北歐各國
  • 奧地利
  • 瑞士
  • 葡萄牙

女性用·子宮頸避孕設備的市場

  • 簡介
    • 輸卵管結紮
    • 機械性避孕
    • 雙極電凝
    • 子宮頸植入
  • 市場分析與預測
  • 推動及阻礙市場要素
    • 推動市場要素
    • 阻礙市場要素
  • 各企業市場佔有率分析

簡稱一覽

目錄
Product Code: iDATA_ EUGYN16_MC_TFS

The transcervical implant market in Europe currently consists of Bayer AG as the sole competitor offering the Essure® product. Essure® was first developed by the company Conceptus in 2001 and was certified for sale throughout Europe, with the first sale occurring in October 2002. In the United States, Essure® was subsequently approved by the FDA on November 4th, 2002. In April 2013, Bayer AG acquired Conceptus to offer Essure® as part of their contraceptive portfolio. In the United Kingdom, the National Institute for Health and Care Excellence approved Essure® in 2009, the last European country to do so. Since Essure® entered the market in 2002, other notable competitors have been the Ovabloc System and the Adiana procedure. Both of these procedures have since been discontinued.

Female sterilization is a permanent form of birth control, requiring invasive surgery to reverse. Female sterilization prevents ova from coming down the fallopian tubes and blocks fertilization by sperm. There are different procedures to perform female sterilization, including tubal ligation, mechanical blockage with a clip or band, bipolar electrocoagulation or transcervical implants. In this report, only the transcervical implant market is covered.

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

EUROPEAN MARKET FOR GYNECOLOGICAL DEVICES OVERVIEW

COMPETITIVE ANALYSIS

MARKET TRENDS

MARKET DEVELOPMENTS

PROCEDURE NUMBERS

MARKETS INCLUDED

KEY REPORT UPDATES

VERSION HISTORY

RESEARCH METHODOLOGY

  • 1.1. RESEARCH SCOPE
  • 1.2. IDATA'S 9-STEP METHODOLOGY
    • 1.2.1. Step 1: Project Initiation & Team Selection
    • 1.2.2. Step 2: Prepare Data Systems and Perform Secondary Research
    • 1.2.3. Step 3: Preparation for Interviews & Questionnaire Design
    • 1.2.4. Step 4: Performing Primary Research
    • 1.2.5. Step 5: Research Analysis: Establishing Baseline Estimates
    • 1.2.6. Step 6: Market Forecast and Analysis
    • 1.2.7. Step 7: Identify Strategic Opportunities
    • 1.2.8. Step 8: Final Review and Market Release
    • 1.2.9. Step 9: Customer Feedback and Market Monitoring

COUNTRY PROFILES

  • 2.1. INTRODUCTION
    • 2.1.1.1. Population
    • 2.1.1.2. Median Age
    • 2.1.1.3. GDP Per Capita
    • 2.1.1.4. Price Index
  • 2.2. GERMANY
  • 2.3. FRANCE
  • 2.4. UNITED KINGDOM
  • 2.5. ITALY
  • 2.6. SPAIN
  • 2.7. BENELUX
  • 2.8. SCANDINAVIA
  • 2.9. AUSTRIA
  • 2.10. SWITZERLAND
  • 2.11. PORTUGAL

TRANSCERVICAL FEMALE STERILIZATION MARKET

  • 3.1. INTRODUCTION
    • 3.1.1. Tubal Ligation
    • 3.1.2. Mechanical Sterilization
    • 3.1.3. Bipolar Electrocoagulation
    • 3.1.4. Transcervical Implant
  • 3.2. MARKET ANALYSIS AND FORECAST
  • 3.3. DRIVERS AND LIMITERS
    • 3.3.1. Market Drivers
    • 3.3.2. Market Limiters
  • 3.4. COMPETITIVE MARKET SHARE ANALYSIS

ABBREVIATIONS

Back to Top